Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With Metformin
Clinical trial NCT06571591 · COMPLETED
Trial details
- NCT number
- NCT06571591
- Sponsor
- Celltrion
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-27
- Primary completion
- 2026-04-16
- Enrollment
- 606
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.